Rite Aid Corporation (RAD): Price and Financial Metrics

Rite Aid Corporation (RAD)

Today's Latest Price: $13.13 USD

0.25 (1.94%)

Updated May 29 4:10pm

Add RAD to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 3 in Medical - Drug Stores

See all "A" rated Strong Buy stocks

RAD Stock Summary

  • Rite Aid Corp's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 99.21% of US listed stocks.
  • With a price/sales ratio of 0.03, Rite Aid Corp has a higher such ratio than only 1.65% of stocks in our set.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 11.15 for Rite Aid Corp; that's greater than it is for 94.79% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Rite Aid Corp are CORE, MAT, SMRT, SUMR, and HBP.
  • Visit RAD's SEC page to see the company's official filings. To visit the company's web site, go to www.riteaid.com.
RAD Daily Price Range
RAD 52-Week Price Range

RAD Stock Price Chart More Charts

RAD Price/Volume Stats

Current price $13.13 52-week high $23.88
Prev. close $12.88 52-week low $5.04
Day low $12.66 Volume 2,795,085
Day high $13.28 Avg. volume 5,628,260
50-day MA $13.70 Dividend yield N/A
200-day MA $11.31 Market Cap 718.25M

Rite Aid Corporation (RAD) Company Bio

Rite Aid Corporation operates a chain of retail drugstores in the United States. The company sells prescription drugs and a range of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products. The company was founded in 1927 and is based in Camp Hill, Pennsylvania.

RAD Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:

We started the process of determining a valid price forecast for Rite Aid Corp with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Rite Aid Corp ranked in the 53th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 23.17%. As for the metrics that stood out in our discounted cash flow analysis of Rite Aid Corp, consider:

  • Interest coverage, a measure of earnings relative to interest payments, is 0.72 -- which is good for besting only 22.93% of its peer stocks (US stocks in the Consumer Defensive sector with positive cash flow).
  • The company's compound free cash flow growth rate over the past 5.82 years comes in at -0.04%; that's greater than only 22.44% of US stocks we're applying DCF forecasting to.
  • 11% of the company's capital comes from equity, which is greater than just 4.15% of stocks in our cash flow based forecasting set.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

For other companies in the Consumer Defensive that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as RAD, try HELE, KR, ANDE, BUD, and DL.

RAD Latest News Stream

Event/TimeNews Detail
Loading, please wait...

RAD Latest Social Stream

Loading social stream, please wait...

View Full RAD Social Stream

Latest RAD News From Around the Web

Below are the latest news stories about Rite Aid Corp that investors may wish to consider to help them evaluate RAD as an investment opportunity.

Ohio counties sue CVS, Walgreens, Rite Aid, Walmart and Giant Eagle for 'fueling opioid epidemic'

CLEVELAND (AP) - Five retail chains flooded two Ohio counties with tens of millions of prescription painkillers through their pharmacies while taking few if…

Daily Mail Online | May 28, 2020

Suit alleges CVS, Walgreens, Rite Aid, Walmart and Giant Eagle fueled a painkiller crisis that resulted in over 430,000 deaths

The retail chains are accused of flooding two Ohio counties with tens of millions of prescription painkillers through their pharmacies.

Yahoo | May 28, 2020

Big Pharmacy Chains Also Fed the Opioid Epidemic, Court Filing Says

New details emerge in a lawsuit asserting that chains including CVS, Rite Aid and Walgreens sold millions of pills in small towns but rarely flagged suspicious orders to authorities.

New York Times | May 27, 2020

Pharmacies Gearing Up For Flu Vaccine Season

Coronavirus has made good news few and far between. In the midst of so much global anxiety, it's nice to reflect on the silver linings culminating from this catastrophe. To me, that glimmer of positive news is people taking better care of themselves going forward.

Yahoo | May 27, 2020

FOCUS-Fears of coronavirus second wave prompt flu push at U.S. pharmacies, drugmakers

U.S. pharmacy chains are preparing a big push for flu vaccinations when the season kicks off in October, hoping to curb tens of thousands of serious cases that could coincide with a second wave of coronavirus infections. CVS Health Corp, one of the largest U.S. pharmacies, said it is working to ensure it has vaccine doses available for an anticipated surge in customers seeking shots to protect against seasonal influenza. Rival chain Rite Aid Corp has ordered 40 percent more vaccine doses to meet the expected demand.

Yahoo | May 26, 2020

Read More 'RAD' Stories Here

RAD Price Returns

1-mo -16.37%
3-mo -3.60%
6-mo 44.92%
1-year 68.98%
3-year -81.03%
5-year -92.47%
YTD -15.13%
2019 8.94%
2018 -63.96%
2017 -76.09%
2016 5.10%
2015 4.26%

Continue Researching RAD

Want to see what other sources are saying about Rite Aid Corp's financials and stock price? Try the links below:

Rite Aid Corp (RAD) Stock Price | Nasdaq
Rite Aid Corp (RAD) Stock Quote, History and News - Yahoo Finance
Rite Aid Corp (RAD) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 1.0177 seconds.